• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

I was one of the cso's fired recently and can't even seem to get another temp job





thats ok neither can any of the amylin reps novo hired no one in my region from there. lol contract or not it does not matter. Get out of this aweful industry it is not what it used to be.